Roach M 3rd, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti RK, Han S, Thomas CR Jr, Shipley WS. Phase III trial com-paring whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003;21:1904-1911.
 Lawton CA, DeSilvio M, Roach M III, et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys 2007;69:646–655.
 Aizer AA, Yu JB, McKeon AM, Decker RH, Colberg JW, Peschel RE. Whole Pelvic Radiotherapy Versus Prostate Only Radiotherapy in THE Management of Locally Advanced or Aggressive Prostate Adenocarcinoma. Int J Radiat Oncol Biol Phys 2009 (in press).
 Chung HT, Xia P, Chan LW, Park-Somers E, Roach M III. Dose image-guided radiotherapy improve toxicity profile in whole pelvictreated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys 2008;73:53-60.
 Pollack A, Alexandra LH, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma C-MC, McNeeley SW, Buyyounouski Mk, Price RA Jr. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypo-fractionation dose escalation trial. Int J Radiat Oncol Biol Phys 2006;64:518-526.
 Hsu A, Pawlicki T, Luxton G, hara W, King CR. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes. Int J Radiat Oncol Biol Phys 2007;68:898-902.
 Muren LP, Wasb? E, Helle SI, Hysing LB, Karlsdottir A, Odland OH, Valen H, Ekerold R, Johannessen DC. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences. Int J Radiat Oncol Biol Phys 2008;71:1034-1041.
 Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63:765-71.
 Chan LW, Xia P, Gottschalk AR, Akazawa M, Scala M, Pickett B, Hsu I-C, Speight J, Roach M III. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;72:69-77.
 Liu B, Lerma FA, Patel S, Amin P, Feng Y, Yi BY, Yu C. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy. Radiother Oncol 2008; 88:67-76.
 Q. Zhang, M. Chan, Y. Song and Burman, “Three Di-mensional Expansion of Margins for Single-Fraction Treatments: Stereotactic Radiosurgery Brain Cases,” In-ternational Journal of Medical Physics, Clinical Engi-neering and Radiation Oncology, Vol. 1, No. 2, 2012, pp. 15-22.
 Crevoisier RD, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys 2007; 68:1529-1536.
 Bylund KC, Bayouth JE, Smith MC, Hass AC, Bhatia SK, Buatti JM. Analysis of interfraction prostate motion using megavoltage cone beam computed tomography. Int J Ra-diat Oncol Biol Phys 2008; 72:949-956.
 Sripadam R, Stratford J, Henry AM, Jackson A, Moore CJ, Price P. Rectal motion can reduce CTV coverage and increase rectal dose during prostate radiotherapy: A daily cone-beam CT study. Radiother Oncol 2009; 90:312-317.
 Lerma FA, Liu B, Wang Z, Yi B, Amin P, Liu S, Feng Y, Yu CX. Role of Image guided patient repositioning and online planning in localized prostate cancer radiotherapy. Radiother Oncol 2009 (accepted).
 Kaus MR, Brock KK, Pekar V, Dawson LA, Nichol AM, Jaffray DA. Assessment of a model-based deformable image registration approach for radiation therapy planning. Int J Radiat Oncol Biol Phys 2007; 68:572-80.